Table 1_Association between immune-related adverse events and recurrence dynamics under adjuvant anti–PD-1 therapy in resected melanoma.docx
Introduction<p>Adjuvant anti–PD-1 therapy has significantly improved recurrence-free survival (RFS) in patients with resected high-risk melanoma, yet a substantial proportion still relapse. Identifying predictors of recurrence remains a clinical priority.</p>Methods<p>We retrospect...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|